Inflammation and Cancer: Causes and Consequences

Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients – analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO

(2009) Rohini Sharma et al.   BMC CANCER

Systemic inflammation, nutritional status and survival in patients with cancer

(2009) Donald C McMillan   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma

(2008) Richard A. Smith et al.   AMERICAN JOURNAL OF SURGERY

C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer

(2008) Tomasz M. Beer et al.   CANCER

Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy

(2008) Markos Leggas et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies

(2008) Konstantinos K. Tsilidis et al.   INTERNATIONAL JOURNAL OF CANCER

External Validation of a Biomarker-Based Preoperative Nomogram Predicts Biochemical Recurrence After Radical Prostatectomy

(2008) Shahrokh F. Shariat et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE